SCHEMBL8380943

SCHEMBL8380943

COC(NC(=O)c1ccccc1)OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.53
TSHR P16473 2/20 0.52
ALDH1A1 P00352 5/20 0.49
LMNA P02545 4/20 0.49
HPGD P15428 3/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
SLC1A2 P43004 1/20 0.49
HDAC3 O15379 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
IDO1 P14902 1/20 0.48
ALOX15 P16050 1/20 0.48
HDAC1 Q13547 1/20 0.48
CA9 Q16790 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31575774 0.82 ALDH1A1 (0.51) GAATSHRALDH1A1LMNAHPGD
SCHEMBL155518 0.81 MLYCD (0.58) GAATSHRALDH1A1LMNAHPGD
SCHEMBL29772431 0.81 MLYCD (0.58) GAATSHRALDH1A1LMNAHPGD
SCHEMBL24998749 0.81 MLYCD (0.58) GAATSHRALDH1A1LMNAHPGD
SCHEMBL13841481 0.81 GAA (0.50) GAATSHRALDH1A1LMNAHPGD
SCHEMBL28273516 0.81 HPGD (0.50) GAATSHRALDH1A1LMNAHPGD
SCHEMBL27822263 0.81 ALDH1A1 (0.53) GAATSHRALDH1A1LMNAHPGD
SCHEMBL8698619 0.79 LMNA (0.53) GAATSHRALDH1A1LMNAHPGD
SCHEMBL712573 0.79 GAA (0.56) GAATSHRALDH1A1LMNAHPGD
SCHEMBL28680553 0.79 GAA (0.49) GAATSHRALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110382490-A Quinazoline compounds and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2019-10-25 CN disclosed
CN-105916843-B Octahydrocyclopenta [ c ] pyrrole selective NR2B negative regulator 科登特治疗公司 2019-09-20 CN disclosed
CN-110167935-A The propionic acid that 3- as α V integrin inhibitors is substituted 百时美施贵宝公司 2019-08-23 CN disclosed
CN-108484454-A A method of sulfonyl fluoride compound is prepared by carbon-hydrogen bond activation 武汉理工大学 2018-09-04 CN disclosed
CN-108239074-A Quinazoline compounds and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2018-07-03 CN disclosed
CN-108239075-A Quinazoline compounds and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2018-07-03 CN disclosed
CN-108239076-A Quinazoline compounds and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2018-07-03 CN disclosed
CN-107216336-A Camptothecine compounds and its preparation and use 李雨亮 2017-09-29 CN disclosed
CN-107108601-A Glycosidase inhibitor 阿森纽荣股份公司 2017-08-29 CN disclosed
CN-105916843-A Octahydrocyclopenta [ c ] pyrrole selective NR2B negative regulator 吕克疗法股份有限公司 2016-08-31 CN disclosed
CN-102459242-B Phenoxymethyl heterocyclic compounds FORUM PHARMACEUTICALS INC. (US) 2015-08-26 CN disclosed
CN-104520296-A Pyrrolopyridinone derivatives as TTX-S blockers RAQUALIA PHARMA INC 2015-04-15 CN disclosed
CN-102131801-B 1, 2 disubstituted heterocyclic compounds FORUM PHARMACEUTICALS INC 2015-04-08 CN disclosed
EP-0906268-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1999-04-07 EP disclosed
WO-1997045397-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1997-12-04 WO disclosed